Barzolvolimab Shows Promise for Cold Urticaria and Dermographism

(MedPage Today) -- The investigational monoclonal antibody barzolvolimab significantly improved provocation test outcomes and reduced symptoms compared with placebo in patients with cold urticaria and symptomatic dermographism, according to results...